SRC was found at significantly higher levels in the serum of de novo patients with AML compared to healthy individuals and negatively correlated with OS, which suggests that SRC may play a role in AML progression and poor prognosis [78]. The gene discussed is SRC; the disease is acute myeloid leukemia.